These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31054001)

  • 1. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
    Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
    Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sentinel Margin: Intraoperative
    van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
    Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
    Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
    Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
    Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
    Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
    Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.
    Krishnan G; van den Berg NS; Nishio N; Juniper G; Pei J; Zhou Q; Lu G; Lee YJ; Ramos K; Iagaru AH; Baik FM; Colevas AD; Martin BA; Rosenthal EL
    Theranostics; 2021; 11(15):7188-7198. PubMed ID: 34158844
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety.
    Bernhard W; Barreto K; El-Sayed A; Gonzalez C; Viswas RS; Toledo D; Casaco A; DeCoteau J; Fonge H; Geyer CR
    BMC Cancer; 2021 Mar; 21(1):270. PubMed ID: 33711962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
    Rosenthal EL; Moore LS; Tipirneni K; de Boer E; Stevens TM; Hartman YE; Carroll WR; Zinn KR; Warram JM
    Clin Cancer Res; 2017 Aug; 23(16):4744-4752. PubMed ID: 28446503
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging.
    Pei J; Juniper G; van den Berg NS; Nisho N; Broadt T; Welch AR; Yi GS; Raymundo RC; Chirita SU; Lu G; Krishnan G; Lee YJ; Kapoor S; Zhou Q; Colevas AD; Lui NS; Poultsides GA; Li G; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2021 Feb; 23(1):109-116. PubMed ID: 32880818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
    Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
    Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
    Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M
    J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.
    Sweeny L; Prince A; Patel N; Moore LS; Rosenthal EL; Hughley BB; Warram JM
    Laryngoscope; 2016 Dec; 126(12):E387-E395. PubMed ID: 27576611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
    Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
    Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.